Thromboprophylaxis in gynecologic cancer surgery: Is extended prophylaxis with low molecular weight heparin justified?

European Journal of Obstetrics & Gynecology and Reproductive Biology(2018)

Cited 8|Views7
No score
Abstract
Extended prophylaxis for 28 days with enoxaparin did not improve the rates of VTE following gynecologic oncological surgery in our series compared to the 7-day therapy, although neither was this extended duration associated with adverse events or mortality.
More
Translated text
Key words
Thromboprophylaxis,Gynecologic cancer surgery,Low molecular weight heparin,Venous thromboembolism,Thromboembolic disease
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined